aluates Reports

$ 0.0

Global Influenza (Flu) Antiviral Drugs Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-32Y5762

Global and United States Influenza Flu Antiviral Drugs Market Report Forecast 2022 2028

BUY CHAPTERS

Global Influenza (Flu) Antiviral Drugs Market Insights, Forecast to 2030

Code: QYRE-Auto-32Y5762

Report

December 2024

Pages:125

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Influenza (Flu) Antiviral Drugs Market Size

The global Influenza (Flu) Antiviral Drugs market is projected to grow from US$ 1038.4 million in 2024 to US$ 1352.3 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.5% during the forecast period.

Influenza (Flu) Antiviral Drugs Market

Antiviral drugs are a class of drugs for the specific treatment of viral infections.

The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Influenza (Flu) Antiviral Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Influenza (Flu) Antiviral Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Influenza (Flu) Antiviral Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Influenza (Flu) Antiviral Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Influenza (Flu) Antiviral Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Influenza (Flu) Antiviral Drugs sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Influenza (Flu) Antiviral Drugs Market Report

Report Metric	Details
Report Name	Influenza (Flu) Antiviral Drugs Market
Accounted market size in 2024	US$ 1038.4 million
Forecasted market size in 2030	US$ 1352.3 million
CAGR	4.5
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Penetration and Dehulling Inhibitors DNA Polymerase Inhibitors Reverse Transcriptase Inhibitors Protein Inhibitors Neuraminidase Inhibitors Broad-spectrum Antiviral Drugs
Segment by Application	Hospital Clinic Household Others
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, Johnson & Johnson, Merck, Novartis, AbbVie, Gilead Sciences, GlaxoSmithKline (GSK), Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Teva, Bayer, Novo Nordisk, Allergan, Takeda, Boehringer Ingelheim, Teva Pharmaceutical Industries, Mylan, F. Hoffmann-La Roche, Bristol-Myers-Squibb, Aurobindo Pharma, Cipla
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Influenza (Flu) Antiviral Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Influenza (Flu) Antiviral Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Influenza (Flu) Antiviral Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Influenza (Flu) Antiviral Drugs Market growing?

Ans: The Influenza (Flu) Antiviral Drugs Market witnessing a CAGR of 4.5 during the forecast period 2025-2030.

What is the Influenza (Flu) Antiviral Drugs Market size in 2030?

Ans: The Influenza (Flu) Antiviral Drugs Market size in 2030 will be US$ 1352.3 million.

Who are the main players in the Influenza (Flu) Antiviral Drugs Market report?

Ans: The main players in the Influenza (Flu) Antiviral Drugs Market are Sanofi, Johnson & Johnson, Merck, Novartis, AbbVie, Gilead Sciences, GlaxoSmithKline (GSK), Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Teva, Bayer, Novo Nordisk, Allergan, Takeda, Boehringer Ingelheim, Teva Pharmaceutical Industries, Mylan, F. Hoffmann-La Roche, Bristol-Myers-Squibb, Aurobindo Pharma, Cipla

What are the Application segmentation covered in the Influenza (Flu) Antiviral Drugs Market report?

Ans: The Applications covered in the Influenza (Flu) Antiviral Drugs Market report are Hospital, Clinic, Household, Others

What are the Type segmentation covered in the Influenza (Flu) Antiviral Drugs Market report?

Ans: The Types covered in the Influenza (Flu) Antiviral Drugs Market report are Penetration and Dehulling Inhibitors, DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protein Inhibitors, Neuraminidase Inhibitors, Broad-spectrum Antiviral Drugs

1 Study Coverage

1.1 Influenza (Flu) Antiviral Drugs Product Introduction

1.2 Market by Type

1.2.1 Global Influenza (Flu) Antiviral Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Penetration and Dehulling Inhibitors

1.2.3 DNA Polymerase Inhibitors

1.2.4 Reverse Transcriptase Inhibitors

1.2.5 Protein Inhibitors

1.2.6 Neuraminidase Inhibitors

1.2.7 Broad-spectrum Antiviral Drugs

1.3 Market by Application

1.3.1 Global Influenza (Flu) Antiviral Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Household

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Influenza (Flu) Antiviral Drugs Sales Estimates and Forecasts 2019-2030

2.2 Global Influenza (Flu) Antiviral Drugs Revenue by Region

2.2.1 Global Influenza (Flu) Antiviral Drugs Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Influenza (Flu) Antiviral Drugs Revenue by Region (2019-2024)

2.2.3 Global Influenza (Flu) Antiviral Drugs Revenue by Region (2025-2030)

2.2.4 Global Influenza (Flu) Antiviral Drugs Revenue Market Share by Region (2019-2030)

2.3 Global Influenza (Flu) Antiviral Drugs Sales Estimates and Forecasts 2019-2030

2.4 Global Influenza (Flu) Antiviral Drugs Sales by Region

2.4.1 Global Influenza (Flu) Antiviral Drugs Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Influenza (Flu) Antiviral Drugs Sales by Region (2019-2024)

2.4.3 Global Influenza (Flu) Antiviral Drugs Sales by Region (2025-2030)

2.4.4 Global Influenza (Flu) Antiviral Drugs Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Influenza (Flu) Antiviral Drugs Sales by Manufacturers

3.1.1 Global Influenza (Flu) Antiviral Drugs Sales by Manufacturers (2019-2024)

3.1.2 Global Influenza (Flu) Antiviral Drugs Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Influenza (Flu) Antiviral Drugs in 2023

3.2 Global Influenza (Flu) Antiviral Drugs Revenue by Manufacturers

3.2.1 Global Influenza (Flu) Antiviral Drugs Revenue by Manufacturers (2019-2024)

3.2.2 Global Influenza (Flu) Antiviral Drugs Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Influenza (Flu) Antiviral Drugs Revenue in 2023

3.3 Global Key Players of Influenza (Flu) Antiviral Drugs, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Influenza (Flu) Antiviral Drugs Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Influenza (Flu) Antiviral Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Influenza (Flu) Antiviral Drugs, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Influenza (Flu) Antiviral Drugs, Product Offered and Application

3.8 Global Key Manufacturers of Influenza (Flu) Antiviral Drugs, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Influenza (Flu) Antiviral Drugs Sales by Type

4.1.1 Global Influenza (Flu) Antiviral Drugs Historical Sales by Type (2019-2024)

4.1.2 Global Influenza (Flu) Antiviral Drugs Forecasted Sales by Type (2025-2030)

4.1.3 Global Influenza (Flu) Antiviral Drugs Sales Market Share by Type (2019-2030)

4.2 Global Influenza (Flu) Antiviral Drugs Revenue by Type

4.2.1 Global Influenza (Flu) Antiviral Drugs Historical Revenue by Type (2019-2024)

4.2.2 Global Influenza (Flu) Antiviral Drugs Forecasted Revenue by Type (2025-2030)

4.2.3 Global Influenza (Flu) Antiviral Drugs Revenue Market Share by Type (2019-2030)

4.3 Global Influenza (Flu) Antiviral Drugs Price by Type

4.3.1 Global Influenza (Flu) Antiviral Drugs Price by Type (2019-2024)

4.3.2 Global Influenza (Flu) Antiviral Drugs Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Influenza (Flu) Antiviral Drugs Sales by Application

5.1.1 Global Influenza (Flu) Antiviral Drugs Historical Sales by Application (2019-2024)

5.1.2 Global Influenza (Flu) Antiviral Drugs Forecasted Sales by Application (2025-2030)

5.1.3 Global Influenza (Flu) Antiviral Drugs Sales Market Share by Application (2019-2030)

5.2 Global Influenza (Flu) Antiviral Drugs Revenue by Application

5.2.1 Global Influenza (Flu) Antiviral Drugs Historical Revenue by Application (2019-2024)

5.2.2 Global Influenza (Flu) Antiviral Drugs Forecasted Revenue by Application (2025-2030)

5.2.3 Global Influenza (Flu) Antiviral Drugs Revenue Market Share by Application (2019-2030)

5.3 Global Influenza (Flu) Antiviral Drugs Price by Application

5.3.1 Global Influenza (Flu) Antiviral Drugs Price by Application (2019-2024)

5.3.2 Global Influenza (Flu) Antiviral Drugs Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Influenza (Flu) Antiviral Drugs Market Size by Type

6.1.1 US & Canada Influenza (Flu) Antiviral Drugs Sales by Type (2019-2030)

6.1.2 US & Canada Influenza (Flu) Antiviral Drugs Revenue by Type (2019-2030)

6.2 US & Canada Influenza (Flu) Antiviral Drugs Market Size by Application

6.2.1 US & Canada Influenza (Flu) Antiviral Drugs Sales by Application (2019-2030)

6.2.2 US & Canada Influenza (Flu) Antiviral Drugs Revenue by Application (2019-2030)

6.3 US & Canada Influenza (Flu) Antiviral Drugs Market Size by Country

6.3.1 US & Canada Influenza (Flu) Antiviral Drugs Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Influenza (Flu) Antiviral Drugs Sales by Country (2019-2030)

6.3.3 US & Canada Influenza (Flu) Antiviral Drugs Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Influenza (Flu) Antiviral Drugs Market Size by Type

7.1.1 Europe Influenza (Flu) Antiviral Drugs Sales by Type (2019-2030)

7.1.2 Europe Influenza (Flu) Antiviral Drugs Revenue by Type (2019-2030)

7.2 Europe Influenza (Flu) Antiviral Drugs Market Size by Application

7.2.1 Europe Influenza (Flu) Antiviral Drugs Sales by Application (2019-2030)

7.2.2 Europe Influenza (Flu) Antiviral Drugs Revenue by Application (2019-2030)

7.3 Europe Influenza (Flu) Antiviral Drugs Market Size by Country

7.3.1 Europe Influenza (Flu) Antiviral Drugs Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Influenza (Flu) Antiviral Drugs Sales by Country (2019-2030)

7.3.3 Europe Influenza (Flu) Antiviral Drugs Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Influenza (Flu) Antiviral Drugs Market Size

8.1.1 China Influenza (Flu) Antiviral Drugs Sales (2019-2030)

8.1.2 China Influenza (Flu) Antiviral Drugs Revenue (2019-2030)

8.2 China Influenza (Flu) Antiviral Drugs Market Size by Application

8.2.1 China Influenza (Flu) Antiviral Drugs Sales by Application (2019-2030)

8.2.2 China Influenza (Flu) Antiviral Drugs Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Influenza (Flu) Antiviral Drugs Market Size by Type

9.1.1 Asia Influenza (Flu) Antiviral Drugs Sales by Type (2019-2030)

9.1.2 Asia Influenza (Flu) Antiviral Drugs Revenue by Type (2019-2030)

9.2 Asia Influenza (Flu) Antiviral Drugs Market Size by Application

9.2.1 Asia Influenza (Flu) Antiviral Drugs Sales by Application (2019-2030)

9.2.2 Asia Influenza (Flu) Antiviral Drugs Revenue by Application (2019-2030)

9.3 Asia Influenza (Flu) Antiviral Drugs Sales by Region

9.3.1 Asia Influenza (Flu) Antiviral Drugs Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Influenza (Flu) Antiviral Drugs Revenue by Region (2019-2030)

9.3.3 Asia Influenza (Flu) Antiviral Drugs Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Influenza (Flu) Antiviral Drugs Market Size by Type

10.1.1 Middle East, Africa and Latin America Influenza (Flu) Antiviral Drugs Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Influenza (Flu) Antiviral Drugs Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Influenza (Flu) Antiviral Drugs Market Size by Application

10.2.1 Middle East, Africa and Latin America Influenza (Flu) Antiviral Drugs Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Influenza (Flu) Antiviral Drugs Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Influenza (Flu) Antiviral Drugs Sales by Country

10.3.1 Middle East, Africa and Latin America Influenza (Flu) Antiviral Drugs Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Influenza (Flu) Antiviral Drugs Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Influenza (Flu) Antiviral Drugs Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Pfizer

11.1.1 Pfizer Company Information

11.1.2 Pfizer Overview

11.1.3 Pfizer Influenza (Flu) Antiviral Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Pfizer Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Pfizer Recent Developments

11.2 Roche

11.2.1 Roche Company Information

11.2.2 Roche Overview

11.2.3 Roche Influenza (Flu) Antiviral Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Roche Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Roche Recent Developments

11.3 Sanofi

11.3.1 Sanofi Company Information

11.3.2 Sanofi Overview

11.3.3 Sanofi Influenza (Flu) Antiviral Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Sanofi Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Sanofi Recent Developments

11.4 Johnson & Johnson

11.4.1 Johnson & Johnson Company Information

11.4.2 Johnson & Johnson Overview

11.4.3 Johnson & Johnson Influenza (Flu) Antiviral Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Johnson & Johnson Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Johnson & Johnson Recent Developments

11.5 Merck

11.5.1 Merck Company Information

11.5.2 Merck Overview

11.5.3 Merck Influenza (Flu) Antiviral Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Merck Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Merck Recent Developments

11.6 Novartis

11.6.1 Novartis Company Information

11.6.2 Novartis Overview

11.6.3 Novartis Influenza (Flu) Antiviral Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Novartis Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Novartis Recent Developments

11.7 AbbVie

11.7.1 AbbVie Company Information

11.7.2 AbbVie Overview

11.7.3 AbbVie Influenza (Flu) Antiviral Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 AbbVie Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 AbbVie Recent Developments

11.8 Gilead Sciences

11.8.1 Gilead Sciences Company Information

11.8.2 Gilead Sciences Overview

11.8.3 Gilead Sciences Influenza (Flu) Antiviral Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 Gilead Sciences Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Gilead Sciences Recent Developments

11.9 GlaxoSmithKline (GSK)

11.9.1 GlaxoSmithKline (GSK) Company Information

11.9.2 GlaxoSmithKline (GSK) Overview

11.9.3 GlaxoSmithKline (GSK) Influenza (Flu) Antiviral Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.9.4 GlaxoSmithKline (GSK) Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 GlaxoSmithKline (GSK) Recent Developments

11.10 Amgen

11.10.1 Amgen Company Information

11.10.2 Amgen Overview

11.10.3 Amgen Influenza (Flu) Antiviral Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.10.4 Amgen Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Amgen Recent Developments

11.11 AstraZeneca

11.11.1 AstraZeneca Company Information

11.11.2 AstraZeneca Overview

11.11.3 AstraZeneca Influenza (Flu) Antiviral Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.11.4 AstraZeneca Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 AstraZeneca Recent Developments

11.12 Bristol-Myers Squibb

11.12.1 Bristol-Myers Squibb Company Information

11.12.2 Bristol-Myers Squibb Overview

11.12.3 Bristol-Myers Squibb Influenza (Flu) Antiviral Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.12.4 Bristol-Myers Squibb Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.12.5 Bristol-Myers Squibb Recent Developments

11.13 Eli Lilly

11.13.1 Eli Lilly Company Information

11.13.2 Eli Lilly Overview

11.13.3 Eli Lilly Influenza (Flu) Antiviral Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.13.4 Eli Lilly Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.13.5 Eli Lilly Recent Developments

11.14 Teva

11.14.1 Teva Company Information

11.14.2 Teva Overview

11.14.3 Teva Influenza (Flu) Antiviral Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.14.4 Teva Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.14.5 Teva Recent Developments

11.15 Bayer

11.15.1 Bayer Company Information

11.15.2 Bayer Overview

11.15.3 Bayer Influenza (Flu) Antiviral Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.15.4 Bayer Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.15.5 Bayer Recent Developments

11.16 Novo Nordisk

11.16.1 Novo Nordisk Company Information

11.16.2 Novo Nordisk Overview

11.16.3 Novo Nordisk Influenza (Flu) Antiviral Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.16.4 Novo Nordisk Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.16.5 Novo Nordisk Recent Developments

11.17 Allergan

11.17.1 Allergan Company Information

11.17.2 Allergan Overview

11.17.3 Allergan Influenza (Flu) Antiviral Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.17.4 Allergan Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.17.5 Allergan Recent Developments

11.18 Takeda

11.18.1 Takeda Company Information

11.18.2 Takeda Overview

11.18.3 Takeda Influenza (Flu) Antiviral Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.18.4 Takeda Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.18.5 Takeda Recent Developments

11.19 Boehringer Ingelheim

11.19.1 Boehringer Ingelheim Company Information

11.19.2 Boehringer Ingelheim Overview

11.19.3 Boehringer Ingelheim Influenza (Flu) Antiviral Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.19.4 Boehringer Ingelheim Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.19.5 Boehringer Ingelheim Recent Developments

11.20 Teva Pharmaceutical Industries

11.20.1 Teva Pharmaceutical Industries Company Information

11.20.2 Teva Pharmaceutical Industries Overview

11.20.3 Teva Pharmaceutical Industries Influenza (Flu) Antiviral Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.20.4 Teva Pharmaceutical Industries Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.20.5 Teva Pharmaceutical Industries Recent Developments

11.21 Mylan

11.21.1 Mylan Company Information

11.21.2 Mylan Overview

11.21.3 Mylan Influenza (Flu) Antiviral Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.21.4 Mylan Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.21.5 Mylan Recent Developments

11.22 F. Hoffmann-La Roche

11.22.1 F. Hoffmann-La Roche Company Information

11.22.2 F. Hoffmann-La Roche Overview

11.22.3 F. Hoffmann-La Roche Influenza (Flu) Antiviral Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.22.4 F. Hoffmann-La Roche Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.22.5 F. Hoffmann-La Roche Recent Developments

11.23 Bristol-Myers-Squibb

11.23.1 Bristol-Myers-Squibb Company Information

11.23.2 Bristol-Myers-Squibb Overview

11.23.3 Bristol-Myers-Squibb Influenza (Flu) Antiviral Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.23.4 Bristol-Myers-Squibb Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.23.5 Bristol-Myers-Squibb Recent Developments

11.24 Aurobindo Pharma

11.24.1 Aurobindo Pharma Company Information

11.24.2 Aurobindo Pharma Overview

11.24.3 Aurobindo Pharma Influenza (Flu) Antiviral Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.24.4 Aurobindo Pharma Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.24.5 Aurobindo Pharma Recent Developments

11.25 Cipla

11.25.1 Cipla Company Information

11.25.2 Cipla Overview

11.25.3 Cipla Influenza (Flu) Antiviral Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.25.4 Cipla Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.25.5 Cipla Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Influenza (Flu) Antiviral Drugs Industry Chain Analysis

12.2 Influenza (Flu) Antiviral Drugs Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Influenza (Flu) Antiviral Drugs Production Mode & Process

12.4 Influenza (Flu) Antiviral Drugs Sales and Marketing

12.4.1 Influenza (Flu) Antiviral Drugs Sales Channels

12.4.2 Influenza (Flu) Antiviral Drugs Distributors

12.5 Influenza (Flu) Antiviral Drugs Customers

13 Market Dynamics

13.1 Influenza (Flu) Antiviral Drugs Industry Trends

13.2 Influenza (Flu) Antiviral Drugs Market Drivers

13.3 Influenza (Flu) Antiviral Drugs Market Challenges

13.4 Influenza (Flu) Antiviral Drugs Market Restraints

14 Key Findings in The Global Influenza (Flu) Antiviral Drugs Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

List of Tables

Table 1. Global Influenza (Flu) Antiviral Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Penetration and Dehulling Inhibitors

Table 3. Major Manufacturers of DNA Polymerase Inhibitors

Table 4. Major Manufacturers of Reverse Transcriptase Inhibitors

Table 5. Major Manufacturers of Protein Inhibitors

Table 6. Major Manufacturers of Neuraminidase Inhibitors

Table 7. Major Manufacturers of Broad-spectrum Antiviral Drugs

Table 8. Global Influenza (Flu) Antiviral Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 9. Global Influenza (Flu) Antiviral Drugs Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 10. Global Influenza (Flu) Antiviral Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 11. Global Influenza (Flu) Antiviral Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 12. Global Influenza (Flu) Antiviral Drugs Revenue Market Share by Region (2019-2024)

Table 13. Global Influenza (Flu) Antiviral Drugs Revenue Market Share by Region (2025-2030)

Table 14. Global Influenza (Flu) Antiviral Drugs Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 15. Global Influenza (Flu) Antiviral Drugs Sales by Region (2019-2024) & (K Units)

Table 16. Global Influenza (Flu) Antiviral Drugs Sales by Region (2025-2030) & (K Units)

Table 17. Global Influenza (Flu) Antiviral Drugs Sales Market Share by Region (2019-2024)

Table 18. Global Influenza (Flu) Antiviral Drugs Sales Market Share by Region (2025-2030)

Table 19. Global Influenza (Flu) Antiviral Drugs Sales by Manufacturers (2019-2024) & (K Units)

Table 20. Global Influenza (Flu) Antiviral Drugs Sales Share by Manufacturers (2019-2024)

Table 21. Global Influenza (Flu) Antiviral Drugs Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 22. Global Influenza (Flu) Antiviral Drugs Revenue Share by Manufacturers (2019-2024)

Table 23. Global Key Players of Influenza (Flu) Antiviral Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 24. Influenza (Flu) Antiviral Drugs Price by Manufacturers 2019-2024 (US$/Unit)

Table 25. Global Influenza (Flu) Antiviral Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 26. Global Influenza (Flu) Antiviral Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza (Flu) Antiviral Drugs as of 2023)

Table 27. Global Key Manufacturers of Influenza (Flu) Antiviral Drugs, Manufacturing Base Distribution and Headquarters

Table 28. Global Key Manufacturers of Influenza (Flu) Antiviral Drugs, Product Offered and Application

Table 29. Global Key Manufacturers of Influenza (Flu) Antiviral Drugs, Date of Enter into This Industry

Table 30. Mergers & Acquisitions, Expansion Plans

Table 31. Global Influenza (Flu) Antiviral Drugs Sales by Type (2019-2024) & (K Units)

Table 32. Global Influenza (Flu) Antiviral Drugs Sales by Type (2025-2030) & (K Units)

Table 33. Global Influenza (Flu) Antiviral Drugs Sales Share by Type (2019-2024)

Table 34. Global Influenza (Flu) Antiviral Drugs Sales Share by Type (2025-2030)

Table 35. Global Influenza (Flu) Antiviral Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 36. Global Influenza (Flu) Antiviral Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 37. Global Influenza (Flu) Antiviral Drugs Revenue Share by Type (2019-2024)

Table 38. Global Influenza (Flu) Antiviral Drugs Revenue Share by Type (2025-2030)

Table 39. Influenza (Flu) Antiviral Drugs Price by Type (2019-2024) & (US$/Unit)

Table 40. Global Influenza (Flu) Antiviral Drugs Price Forecast by Type (2025-2030) & (US$/Unit)

Table 41. Global Influenza (Flu) Antiviral Drugs Sales by Application (2019-2024) & (K Units)

Table 42. Global Influenza (Flu) Antiviral Drugs Sales by Application (2025-2030) & (K Units)

Table 43. Global Influenza (Flu) Antiviral Drugs Sales Share by Application (2019-2024)

Table 44. Global Influenza (Flu) Antiviral Drugs Sales Share by Application (2025-2030)

Table 45. Global Influenza (Flu) Antiviral Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 46. Global Influenza (Flu) Antiviral Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 47. Global Influenza (Flu) Antiviral Drugs Revenue Share by Application (2019-2024)

Table 48. Global Influenza (Flu) Antiviral Drugs Revenue Share by Application (2025-2030)

Table 49. Influenza (Flu) Antiviral Drugs Price by Application (2019-2024) & (US$/Unit)

Table 50. Global Influenza (Flu) Antiviral Drugs Price Forecast by Application (2025-2030) & (US$/Unit)

Table 51. US & Canada Influenza (Flu) Antiviral Drugs Sales by Type (2019-2024) & (K Units)

Table 52. US & Canada Influenza (Flu) Antiviral Drugs Sales by Type (2025-2030) & (K Units)

Table 53. US & Canada Influenza (Flu) Antiviral Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 54. US & Canada Influenza (Flu) Antiviral Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 55. US & Canada Influenza (Flu) Antiviral Drugs Sales by Application (2019-2024) & (K Units)

Table 56. US & Canada Influenza (Flu) Antiviral Drugs Sales by Application (2025-2030) & (K Units)

Table 57. US & Canada Influenza (Flu) Antiviral Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 58. US & Canada Influenza (Flu) Antiviral Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 59. US & Canada Influenza (Flu) Antiviral Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 60. US & Canada Influenza (Flu) Antiviral Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 61. US & Canada Influenza (Flu) Antiviral Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 62. US & Canada Influenza (Flu) Antiviral Drugs Sales by Country (2019-2024) & (K Units)

Table 63. US & Canada Influenza (Flu) Antiviral Drugs Sales by Country (2025-2030) & (K Units)

Table 64. Europe Influenza (Flu) Antiviral Drugs Sales by Type (2019-2024) & (K Units)

Table 65. Europe Influenza (Flu) Antiviral Drugs Sales by Type (2025-2030) & (K Units)

Table 66. Europe Influenza (Flu) Antiviral Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 67. Europe Influenza (Flu) Antiviral Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 68. Europe Influenza (Flu) Antiviral Drugs Sales by Application (2019-2024) & (K Units)

Table 69. Europe Influenza (Flu) Antiviral Drugs Sales by Application (2025-2030) & (K Units)

Table 70. Europe Influenza (Flu) Antiviral Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 71. Europe Influenza (Flu) Antiviral Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 72. Europe Influenza (Flu) Antiviral Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 73. Europe Influenza (Flu) Antiviral Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 74. Europe Influenza (Flu) Antiviral Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 75. Europe Influenza (Flu) Antiviral Drugs Sales by Country (2019-2024) & (K Units)

Table 76. Europe Influenza (Flu) Antiviral Drugs Sales by Country (2025-2030) & (K Units)

Table 77. China Influenza (Flu) Antiviral Drugs Sales by Type (2019-2024) & (K Units)

Table 78. China Influenza (Flu) Antiviral Drugs Sales by Type (2025-2030) & (K Units)

Table 79. China Influenza (Flu) Antiviral Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 80. China Influenza (Flu) Antiviral Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 81. China Influenza (Flu) Antiviral Drugs Sales by Application (2019-2024) & (K Units)

Table 82. China Influenza (Flu) Antiviral Drugs Sales by Application (2025-2030) & (K Units)

Table 83. China Influenza (Flu) Antiviral Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 84. China Influenza (Flu) Antiviral Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 85. Asia Influenza (Flu) Antiviral Drugs Sales by Type (2019-2024) & (K Units)

Table 86. Asia Influenza (Flu) Antiviral Drugs Sales by Type (2025-2030) & (K Units)

Table 87. Asia Influenza (Flu) Antiviral Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 88. Asia Influenza (Flu) Antiviral Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 89. Asia Influenza (Flu) Antiviral Drugs Sales by Application (2019-2024) & (K Units)

Table 90. Asia Influenza (Flu) Antiviral Drugs Sales by Application (2025-2030) & (K Units)

Table 91. Asia Influenza (Flu) Antiviral Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 92. Asia Influenza (Flu) Antiviral Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 93. Asia Influenza (Flu) Antiviral Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 94. Asia Influenza (Flu) Antiviral Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 95. Asia Influenza (Flu) Antiviral Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 96. Asia Influenza (Flu) Antiviral Drugs Sales by Region (2019-2024) & (K Units)

Table 97. Asia Influenza (Flu) Antiviral Drugs Sales by Region (2025-2030) & (K Units)

Table 98. Middle East, Africa and Latin America Influenza (Flu) Antiviral Drugs Sales by Type (2019-2024) & (K Units)

Table 99. Middle East, Africa and Latin America Influenza (Flu) Antiviral Drugs Sales by Type (2025-2030) & (K Units)

Table 100. Middle East, Africa and Latin America Influenza (Flu) Antiviral Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 101. Middle East, Africa and Latin America Influenza (Flu) Antiviral Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 102. Middle East, Africa and Latin America Influenza (Flu) Antiviral Drugs Sales by Application (2019-2024) & (K Units)

Table 103. Middle East, Africa and Latin America Influenza (Flu) Antiviral Drugs Sales by Application (2025-2030) & (K Units)

Table 104. Middle East, Africa and Latin America Influenza (Flu) Antiviral Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 105. Middle East, Africa and Latin America Influenza (Flu) Antiviral Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 106. Middle East, Africa and Latin America Influenza (Flu) Antiviral Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 107. Middle East, Africa and Latin America Influenza (Flu) Antiviral Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 108. Middle East, Africa and Latin America Influenza (Flu) Antiviral Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 109. Middle East, Africa and Latin America Influenza (Flu) Antiviral Drugs Sales by Country (2019-2024) & (K Units)

Table 110. Middle East, Africa and Latin America Influenza (Flu) Antiviral Drugs Sales by Country (2025-2030) & (K Units)

Table 111. Pfizer Company Information

Table 112. Pfizer Description and Major Businesses

Table 113. Pfizer Influenza (Flu) Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 114. Pfizer Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 115. Pfizer Recent Developments

Table 116. Roche Company Information

Table 117. Roche Description and Major Businesses

Table 118. Roche Influenza (Flu) Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 119. Roche Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 120. Roche Recent Developments

Table 121. Sanofi Company Information

Table 122. Sanofi Description and Major Businesses

Table 123. Sanofi Influenza (Flu) Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 124. Sanofi Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 125. Sanofi Recent Developments

Table 126. Johnson & Johnson Company Information

Table 127. Johnson & Johnson Description and Major Businesses

Table 128. Johnson & Johnson Influenza (Flu) Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 129. Johnson & Johnson Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 130. Johnson & Johnson Recent Developments

Table 131. Merck Company Information

Table 132. Merck Description and Major Businesses

Table 133. Merck Influenza (Flu) Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 134. Merck Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 135. Merck Recent Developments

Table 136. Novartis Company Information

Table 137. Novartis Description and Major Businesses

Table 138. Novartis Influenza (Flu) Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 139. Novartis Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 140. Novartis Recent Developments

Table 141. AbbVie Company Information

Table 142. AbbVie Description and Major Businesses

Table 143. AbbVie Influenza (Flu) Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 144. AbbVie Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 145. AbbVie Recent Developments

Table 146. Gilead Sciences Company Information

Table 147. Gilead Sciences Description and Major Businesses

Table 148. Gilead Sciences Influenza (Flu) Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 149. Gilead Sciences Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 150. Gilead Sciences Recent Developments

Table 151. GlaxoSmithKline (GSK) Company Information

Table 152. GlaxoSmithKline (GSK) Description and Major Businesses

Table 153. GlaxoSmithKline (GSK) Influenza (Flu) Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 154. GlaxoSmithKline (GSK) Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 155. GlaxoSmithKline (GSK) Recent Developments

Table 156. Amgen Company Information

Table 157. Amgen Description and Major Businesses

Table 158. Amgen Influenza (Flu) Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 159. Amgen Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 160. Amgen Recent Developments

Table 161. AstraZeneca Company Information

Table 162. AstraZeneca Description and Major Businesses

Table 163. AstraZeneca Influenza (Flu) Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 164. AstraZeneca Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 165. AstraZeneca Recent Developments

Table 166. Bristol-Myers Squibb Company Information

Table 167. Bristol-Myers Squibb Description and Major Businesses

Table 168. Bristol-Myers Squibb Influenza (Flu) Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 169. Bristol-Myers Squibb Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 170. Bristol-Myers Squibb Recent Developments

Table 171. Eli Lilly Company Information

Table 172. Eli Lilly Description and Major Businesses

Table 173. Eli Lilly Influenza (Flu) Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 174. Eli Lilly Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 175. Eli Lilly Recent Developments

Table 176. Teva Company Information

Table 177. Teva Description and Major Businesses

Table 178. Teva Influenza (Flu) Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 179. Teva Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 180. Teva Recent Developments

Table 181. Bayer Company Information

Table 182. Bayer Description and Major Businesses

Table 183. Bayer Influenza (Flu) Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 184. Bayer Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 185. Bayer Recent Developments

Table 186. Novo Nordisk Company Information

Table 187. Novo Nordisk Description and Major Businesses

Table 188. Novo Nordisk Influenza (Flu) Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 189. Novo Nordisk Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 190. Novo Nordisk Recent Developments

Table 191. Allergan Company Information

Table 192. Allergan Description and Major Businesses

Table 193. Allergan Influenza (Flu) Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 194. Allergan Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 195. Allergan Recent Developments

Table 196. Takeda Company Information

Table 197. Takeda Description and Major Businesses

Table 198. Takeda Influenza (Flu) Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 199. Takeda Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 200. Takeda Recent Developments

Table 201. Boehringer Ingelheim Company Information

Table 202. Boehringer Ingelheim Description and Major Businesses

Table 203. Boehringer Ingelheim Influenza (Flu) Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 204. Boehringer Ingelheim Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 205. Boehringer Ingelheim Recent Developments

Table 206. Teva Pharmaceutical Industries Company Information

Table 207. Teva Pharmaceutical Industries Description and Major Businesses

Table 208. Teva Pharmaceutical Industries Influenza (Flu) Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 209. Teva Pharmaceutical Industries Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 210. Teva Pharmaceutical Industries Recent Developments

Table 211. Mylan Company Information

Table 212. Mylan Description and Major Businesses

Table 213. Mylan Influenza (Flu) Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 214. Mylan Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 215. Mylan Recent Developments

Table 216. F. Hoffmann-La Roche Company Information

Table 217. F. Hoffmann-La Roche Description and Major Businesses

Table 218. F. Hoffmann-La Roche Influenza (Flu) Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 219. F. Hoffmann-La Roche Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 220. F. Hoffmann-La Roche Recent Developments

Table 221. Bristol-Myers-Squibb Company Information

Table 222. Bristol-Myers-Squibb Description and Major Businesses

Table 223. Bristol-Myers-Squibb Influenza (Flu) Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 224. Bristol-Myers-Squibb Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 225. Bristol-Myers-Squibb Recent Developments

Table 226. Aurobindo Pharma Company Information

Table 227. Aurobindo Pharma Description and Major Businesses

Table 228. Aurobindo Pharma Influenza (Flu) Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 229. Aurobindo Pharma Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 230. Aurobindo Pharma Recent Developments

Table 231. Cipla Company Information

Table 232. Cipla Description and Major Businesses

Table 233. Cipla Influenza (Flu) Antiviral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 234. Cipla Influenza (Flu) Antiviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 235. Cipla Recent Developments

Table 236. Key Raw Materials Lists

Table 237. Raw Materials Key Suppliers Lists

Table 238. Influenza (Flu) Antiviral Drugs Distributors List

Table 239. Influenza (Flu) Antiviral Drugs Customers List

Table 240. Influenza (Flu) Antiviral Drugs Market Trends

Table 241. Influenza (Flu) Antiviral Drugs Market Drivers

Table 242. Influenza (Flu) Antiviral Drugs Market Challenges

Table 243. Influenza (Flu) Antiviral Drugs Market Restraints

Table 244. Research Programs/Design for This Report

Table 245. Key Data Information from Secondary Sources

Table 246. Key Data Information from Primary Sources

List of Figures

Figure 1. Influenza (Flu) Antiviral Drugs Product Picture

Figure 2. Global Influenza (Flu) Antiviral Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Influenza (Flu) Antiviral Drugs Market Share by Type in 2023 & 2030

Figure 4. Penetration and Dehulling Inhibitors Product Picture

Figure 5. DNA Polymerase Inhibitors Product Picture

Figure 6. Reverse Transcriptase Inhibitors Product Picture

Figure 7. Protein Inhibitors Product Picture

Figure 8. Neuraminidase Inhibitors Product Picture

Figure 9. Broad-spectrum Antiviral Drugs Product Picture

Figure 10. Global Influenza (Flu) Antiviral Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 11. Global Influenza (Flu) Antiviral Drugs Market Share by Application in 2023 & 2030

Figure 12. Hospital

Figure 13. Clinic

Figure 14. Household

Figure 15. Others

Figure 16. Influenza (Flu) Antiviral Drugs Report Years Considered

Figure 17. Global Influenza (Flu) Antiviral Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 18. Global Influenza (Flu) Antiviral Drugs Revenue 2019-2030 (US$ Million)

Figure 19. Global Influenza (Flu) Antiviral Drugs Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 20. Global Influenza (Flu) Antiviral Drugs Revenue Market Share by Region (2019-2030)

Figure 21. Global Influenza (Flu) Antiviral Drugs Sales 2019-2030 ((K Units)

Figure 22. Global Influenza (Flu) Antiviral Drugs Sales Market Share by Region (2019-2030)

Figure 23. US & Canada Influenza (Flu) Antiviral Drugs Sales YoY (2019-2030) & (K Units)

Figure 24. US & Canada Influenza (Flu) Antiviral Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 25. Europe Influenza (Flu) Antiviral Drugs Sales YoY (2019-2030) & (K Units)

Figure 26. Europe Influenza (Flu) Antiviral Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 27. China Influenza (Flu) Antiviral Drugs Sales YoY (2019-2030) & (K Units)

Figure 28. China Influenza (Flu) Antiviral Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 29. Asia (excluding China) Influenza (Flu) Antiviral Drugs Sales YoY (2019-2030) & (K Units)

Figure 30. Asia (excluding China) Influenza (Flu) Antiviral Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 31. Middle East, Africa and Latin America Influenza (Flu) Antiviral Drugs Sales YoY (2019-2030) & (K Units)

Figure 32. Middle East, Africa and Latin America Influenza (Flu) Antiviral Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 33. The Influenza (Flu) Antiviral Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 34. The Top 5 and 10 Largest Manufacturers of Influenza (Flu) Antiviral Drugs in the World: Market Share by Influenza (Flu) Antiviral Drugs Revenue in 2023

Figure 35. Global Influenza (Flu) Antiviral Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 36. Global Influenza (Flu) Antiviral Drugs Sales Market Share by Type (2019-2030)

Figure 37. Global Influenza (Flu) Antiviral Drugs Revenue Market Share by Type (2019-2030)

Figure 38. Global Influenza (Flu) Antiviral Drugs Sales Market Share by Application (2019-2030)

Figure 39. Global Influenza (Flu) Antiviral Drugs Revenue Market Share by Application (2019-2030)

Figure 40. US & Canada Influenza (Flu) Antiviral Drugs Sales Market Share by Type (2019-2030)

Figure 41. US & Canada Influenza (Flu) Antiviral Drugs Revenue Market Share by Type (2019-2030)

Figure 42. US & Canada Influenza (Flu) Antiviral Drugs Sales Market Share by Application (2019-2030)

Figure 43. US & Canada Influenza (Flu) Antiviral Drugs Revenue Market Share by Application (2019-2030)

Figure 44. US & Canada Influenza (Flu) Antiviral Drugs Revenue Share by Country (2019-2030)

Figure 45. US & Canada Influenza (Flu) Antiviral Drugs Sales Share by Country (2019-2030)

Figure 46. U.S. Influenza (Flu) Antiviral Drugs Revenue (2019-2030) & (US$ Million)

Figure 47. Canada Influenza (Flu) Antiviral Drugs Revenue (2019-2030) & (US$ Million)

Figure 48. Europe Influenza (Flu) Antiviral Drugs Sales Market Share by Type (2019-2030)

Figure 49. Europe Influenza (Flu) Antiviral Drugs Revenue Market Share by Type (2019-2030)

Figure 50. Europe Influenza (Flu) Antiviral Drugs Sales Market Share by Application (2019-2030)

Figure 51. Europe Influenza (Flu) Antiviral Drugs Revenue Market Share by Application (2019-2030)

Figure 52. Europe Influenza (Flu) Antiviral Drugs Revenue Share by Country (2019-2030)

Figure 53. Europe Influenza (Flu) Antiviral Drugs Sales Share by Country (2019-2030)

Figure 54. Germany Influenza (Flu) Antiviral Drugs Revenue (2019-2030) & (US$ Million)

Figure 55. France Influenza (Flu) Antiviral Drugs Revenue (2019-2030) & (US$ Million)

Figure 56. U.K. Influenza (Flu) Antiviral Drugs Revenue (2019-2030) & (US$ Million)

Figure 57. Italy Influenza (Flu) Antiviral Drugs Revenue (2019-2030) & (US$ Million)

Figure 58. Russia Influenza (Flu) Antiviral Drugs Revenue (2019-2030) & (US$ Million)

Figure 59. China Influenza (Flu) Antiviral Drugs Sales Market Share by Type (2019-2030)

Figure 60. China Influenza (Flu) Antiviral Drugs Revenue Market Share by Type (2019-2030)

Figure 61. China Influenza (Flu) Antiviral Drugs Sales Market Share by Application (2019-2030)

Figure 62. China Influenza (Flu) Antiviral Drugs Revenue Market Share by Application (2019-2030)

Figure 63. Asia Influenza (Flu) Antiviral Drugs Sales Market Share by Type (2019-2030)

Figure 64. Asia Influenza (Flu) Antiviral Drugs Revenue Market Share by Type (2019-2030)

Figure 65. Asia Influenza (Flu) Antiviral Drugs Sales Market Share by Application (2019-2030)

Figure 66. Asia Influenza (Flu) Antiviral Drugs Revenue Market Share by Application (2019-2030)

Figure 67. Asia Influenza (Flu) Antiviral Drugs Revenue Share by Region (2019-2030)

Figure 68. Asia Influenza (Flu) Antiviral Drugs Sales Share by Region (2019-2030)

Figure 69. Japan Influenza (Flu) Antiviral Drugs Revenue (2019-2030) & (US$ Million)

Figure 70. South Korea Influenza (Flu) Antiviral Drugs Revenue (2019-2030) & (US$ Million)

Figure 71. China Taiwan Influenza (Flu) Antiviral Drugs Revenue (2019-2030) & (US$ Million)

Figure 72. Southeast Asia Influenza (Flu) Antiviral Drugs Revenue (2019-2030) & (US$ Million)

Figure 73. India Influenza (Flu) Antiviral Drugs Revenue (2019-2030) & (US$ Million)

Figure 74. Middle East, Africa and Latin America Influenza (Flu) Antiviral Drugs Sales Market Share by Type (2019-2030)

Figure 75. Middle East, Africa and Latin America Influenza (Flu) Antiviral Drugs Revenue Market Share by Type (2019-2030)

Figure 76. Middle East, Africa and Latin America Influenza (Flu) Antiviral Drugs Sales Market Share by Application (2019-2030)

Figure 77. Middle East, Africa and Latin America Influenza (Flu) Antiviral Drugs Revenue Market Share by Application (2019-2030)

Figure 78. Middle East, Africa and Latin America Influenza (Flu) Antiviral Drugs Revenue Share by Country (2019-2030)

Figure 79. Middle East, Africa and Latin America Influenza (Flu) Antiviral Drugs Sales Share by Country (2019-2030)

Figure 80. Brazil Influenza (Flu) Antiviral Drugs Revenue (2019-2030) & (US$ Million)

Figure 81. Mexico Influenza (Flu) Antiviral Drugs Revenue (2019-2030) & (US$ Million)

Figure 82. Turkey Influenza (Flu) Antiviral Drugs Revenue (2019-2030) & (US$ Million)

Figure 83. Israel Influenza (Flu) Antiviral Drugs Revenue (2019-2030) & (US$ Million)

Figure 84. GCC Countries Influenza (Flu) Antiviral Drugs Revenue (2019-2030) & (US$ Million)

Figure 85. Influenza (Flu) Antiviral Drugs Value Chain

Figure 86. Influenza (Flu) Antiviral Drugs Production Process_

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Influenza (Flu) Antiviral Drugs Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-32Y5762

Global Influenza (Flu) Antiviral Drugs Market Insights, Forecast to 2030

FEATURED COMPANIES

Influenza (Flu) Antiviral Drugs Market Size

Influenza (Flu) Antiviral Drugs Market

Scope of Influenza (Flu) Antiviral Drugs Market Report

Chapter Outline

FAQ for this report

How fast is Influenza (Flu) Antiviral Drugs Market growing?

What is the Influenza (Flu) Antiviral Drugs Market size in 2030?

Who are the main players in the Influenza (Flu) Antiviral Drugs Market report?

What are the Application segmentation covered in the Influenza (Flu) Antiviral Drugs Market report?

What are the Type segmentation covered in the Influenza (Flu) Antiviral Drugs Market report?

FEATURED COMPANIES